logo
Sign in

RCAR Stock Price, Chart, Stats & News

RenovaCare, Inc.
Save

RenovaCare, Inc. (RCAR) does not currently pay a dividend.

8,735
Market cap
Current P/E
Forward P/E

RCAR chart

1M
3M
1Y
5Y
Loading chart...

About

Health care
Sector
Biotechnology
Industry

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs.

Similar securities

Based on sector and market capitalization

Report issue